Cartilago receives “Notice of allowance” in the USA for its regenerative medicine patent application for osteoarthritis and dermal indications

27 February 2023ROME, Italy Cartilago SRL (”Cartilago”), a clinical stage regenerative medicine company founded by Cube Labs, announced today that the United States Patent & Trademark Office (”USPTO”) has issued…

Continue ReadingCartilago receives “Notice of allowance” in the USA for its regenerative medicine patent application for osteoarthritis and dermal indications

Cartilago announces clinical study results confirming the efficacy of regen longevity in reducing periocular wrinkles

Rome, Italy  11th November, 2022 – Cartilago, a clinical stage regenerative medicine company founded by Cube Labs, announced today the results from an analysis of 21 subjects with a mean…

Continue ReadingCartilago announces clinical study results confirming the efficacy of regen longevity in reducing periocular wrinkles